OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels

@article{Bunt2012OTX2SA,
  title={OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels},
  author={Jens Bunt and Nancy A. Hasselt and Danny A Zwijnenburg and Jan Koster and Rogier Versteeg and Marcel Kool},
  journal={Acta Neuropathologica},
  year={2012},
  volume={125},
  pages={385-394}
}
Recent studies showed frequent mutations in histone H3 lysine 27 (H3K27) demethylases in medulloblastomas of Group 3 and Group 4, suggesting a role for H3K27 methylation in these tumors. Indeed, trimethylated H3K27 (H3K27me3) levels were shown to be higher in Group 3 and 4 tumors compared to WNT and SHH medulloblastomas, also in tumors without detectable mutations in demethylases. Here, we report that polycomb genes, required for H3K27 methylation, are consistently upregulated in Group 3 and 4… 

OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.

TLDR
Using chromatin profiling, it is found that the transcription factor OTX2 acts as a pioneer factor and, in cooperation with NEUROD1, controls the Group 3 medulloblastoma active enhancer landscape.

An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate

TLDR
It is shown that OTX2 regulates PAX3 to induce neural de-differentiation and promote tumourigenesis in Group 3 medulloblastoma.

OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma.

TLDR
The interaction pathways and binding partners involved in OTX2 function, its usefulness as a molecular marker for risk stratification and prognosis, and the mechanism by which it drives tumor maintenance are defined.

Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma

TLDR
It is shown that the transcription factor orthodenticle homeobox 2 (OTX2) promotes self‐renewal while inhibiting differentiation in vitro and increases tumor initiation from MB stem/progenitor cells in vivo and that RHO signaling is contributing to the OTX2 KD phenotype.

A Novel Oncogenic Function of PRC2 Heterogeneity in Medulloblastoma

TLDR
It is shown that IGF2 mediated the oncogenic effects of PRC2 heterogeneity in tumor growth and grew faster than did control wildtype tumors and expressed increased levels of oncogenes such as Igf2.

Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-&bgr;–OTX2–SNAIL via PTEN inhibition

TLDR
Using whole exome sequencing technology in metastatic medulloblastoma primary tumour cells, 23 common 'non-synonymous homozygous' deleterious gene variants are defined as part of the protein molecular network of relevance for metastatic processes.

Discovery of small molecule antagonists of human Retinoblastoma Binding Protein 4 (RBBP4)

TLDR
The first small molecule antagonists of the RBBP4 top pocket are discovered, competing with interacting peptides from proteins such as BCL11A and histone H3, and the first crystal structure of R BBP4 in complex with a small molecule is determined.

The Role of Chromatin Remodeling in Medulloblastoma

TLDR
The mechanisms by which these chromatin remodelers are dysregulated in MB are examined, and the consequences both for future basic research and for translation to the clinic, will be examined.

Using zebrafish to elucidate the epigenetic mechanisms controlling neurogenesis and brain tumorigenesis

TLDR
This work demonstrates Rbbp4 is essential for zebrafish brain development and show it has distinct requirements in neural stem and progenitor cells, and indicates RBBP4 is required to prevent DNA-damage and apoptosis in neural progenitors or newborn neurons.

The role and prospect of JMJD3 in stem cells and cancer.

References

SHOWING 1-10 OF 34 REFERENCES

Joint Binding of OTX2 and MYC in Promotor Regions Is Associated with High Gene Expression in Medulloblastoma

TLDR
OTX2-binding sequences are depleted near TSSs in the genome, providing an explanation for the observed bi-modal distribution of OTX2 binding and suggesting an important functional interaction between OTX 2 and MYC in regulating gene expression in medulloblastoma.

Regulation of Cell Cycle Genes and Induction of Senescence by Overexpression of OTX2 in Medulloblastoma Cell Lines

TLDR
It is hypothesized that the imbalance in cell cycle stimulation by OTX2 leads to cellular senescence either by activating the P53 pathway or through the induction of secretory factors.

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

TLDR
GSK126, a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity, decreases global H3K27me3 levels and reactivates silenced PRC2 target genes and markedly inhibits the growth of EzH2 mutant DLBCL xenografts in mice are demonstrated.

OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.

TLDR
Analysis of a large cohort of primary medulloblastomas revealed frequent focal copy number gain of a region minimally containing OTX2 as a single gene, and Mechanistic investigations revealed upregulation of MYC as a potential mechanism whereby OTx2 promotes tumor progression.

OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells

TLDR
It is demonstrated that OTX2 is essential in medulloblastoma and directly drives proliferation by regulation of cell cycle genes.

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.

TLDR
The results demonstrate the unique feature of DZNep as a novel chromatin remodeling compound and suggest that pharmacologic reversal of PRC2-mediated gene repression by DzNep may constitute a novel approach for cancer therapy.

ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity

TLDR
This work has used ChIP-seq to generate genome-wide maps of H3K27me3 enrichment, and has identified three enrichment profiles with distinct regulatory consequences, including an enrichment profile with a peak in the promoter of genes that is associated with active transcription.

OTX1 and OTX2 Expression Correlates With the Clinicopathologic Classification of Medulloblastomas

TLDR
Results suggest that both nodular/desmoplastic and at least part of the classic medulloblastomas originate from cells of the EGL, albeit from different regions.

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

TLDR
Copy number aberrations of genes with critical roles in writing, reading, removing and blocking the state of histone lysine methylation, particularly at H3K9, suggest that defective control of the histone code contributes to the pathogenesis of medulloblastoma.

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.

TLDR
Observations suggest that OTX2 is essential for the pathogenesis of anaplastic medulloblastomas and that these tumors may be amenable to therapy with all-trans retinoic acid.